Jeil Pharma Holdings Inc (KRX:002620)

Jeil Pharma Holdings Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	59,821	37,039	34,760	28,581	20,183
Short-Term Investments	16,062	22,092	18,643	18,643	9,778
Cash & Short-Term Investments	75,883	59,131	53,403	47,224	29,961
Cash Growth	28.33%	10.73%	13.08%	57.62%	-0.50%
Accounts Receivable	188,185	178,437	162,403	149,681	162,013
Other Receivables	13,437	15,743	15,749	15,305	13,588
Receivables	201,621	194,180	178,152	164,986	175,601
Inventory	123,669	125,280	113,266	114,243	124,150
Prepaid Expenses	257.41	370.95	334.14	210.64	189.94
Other Current Assets	8,130	5,565	7,762	8,481	5,171
Total Current Assets	409,561	384,527	352,916	335,144	335,074
Property, Plant & Equipment	243,942	228,862	233,120	212,965	170,479
Long-Term Investments	93,756	87,116	83,167	79,022	69,996
Goodwill	-	44,862	73,466	151,801	168,815
Other Intangible Assets	5,384	4,532	3,978	3,781	4,118
Long-Term Accounts Receivable	-0	-0	-0	-0	-0
Long-Term Deferred Tax Assets	7,630	5,449	188.47	1,452	3,457
Long-Term Deferred Charges	8,378	8,561	5,494	-	-
Other Long-Term Assets	121,784	116,087	113,347	108,256	135,456
Total Assets	890,433	879,997	865,677	892,421	887,395
Accounts Payable	146,189	154,050	162,967	159,388	149,265
Accrued Expenses	379.18	289.4	219.46	144.54	170.17
Short-Term Debt	141,872	195,937	141,247	88,033	130,510
Current Portion of Long-Term Debt	-	5,800	3,200	6,125	6,125
Current Portion of Leases	672.57	707.58	692.18	806.97	574.21
Current Income Taxes Payable	3,840	774.71	1,160	684.79	4,737
Other Current Liabilities	85,039	55,077	49,019	42,841	35,937
Total Current Liabilities	377,991	412,636	358,505	298,024	327,317
Long-Term Debt	11,900	10,500	16,300	18,531	12,368
Long-Term Leases	767.2	1,198	1,177	1,576	216.45
Long-Term Deferred Tax Liabilities	40,892	37,618	35,755	37,747	31,826
Other Long-Term Liabilities	5,152	5,180	31,421	32,672	7,256
Total Liabilities	453,036	477,811	445,885	392,108	388,111
Common Stock	7,987	7,987	7,987	7,987	7,987
Additional Paid-In Capital	201,825	176,522	176,058	176,384	173,990
Retained Earnings	26,146	79,119	98,245	172,151	175,785
Treasury Stock	-3,422	-3,422	-3,422	-3,422	-3,422
Comprehensive Income & Other	74,414	59,256	58,898	58,631	53,112
Total Common Equity	306,950	319,461	337,765	411,731	407,452
Minority Interest	130,447	82,725	82,028	88,583	91,832
Shareholders' Equity	437,397	402,186	419,792	500,314	499,284
Total Liabilities & Equity	890,433	879,997	865,677	892,421	887,395
Total Debt	155,212	214,143	162,616	115,072	149,794
Net Cash (Debt)	-79,329	-155,012	-109,213	-67,848	-119,832
Net Cash Per Share	-5168.22	-10102.14	-7114.36	-4419.76	-7806.10
Filing Date Shares Outstanding	15.34	15.35	15.35	15.35	15.35
Total Common Shares Outstanding	15.34	15.35	15.35	15.35	15.35
Working Capital	31,570	-28,109	-5,588	37,120	7,757
Book Value Per Share	20004.55	20810.28	22002.60	26820.87	26542.15
Tangible Book Value	301,566	270,066	260,320	256,148	234,519
Tangible Book Value Per Share	19653.67	17592.61	16957.74	16685.95	15276.97
Land	119,324	98,147	98,120	83,677	63,100
Buildings	142,982	140,779	140,778	137,880	120,479
Machinery	107,760	107,539	101,172	84,428	79,522
Construction In Progress	4,923	3,269	3,851	11,778	7,583

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.